About Specializations

Med Sp. z o.o. is a clinical trial site located in Poland, specializing in the study of Chronic Kidney Disease and Albuminuria, as well as Non-Muscle Invasive Bladder Cancer.

Medical Center localisation

Ul. Polnej Rozy 6/u2
02-798 Warsaw, Poland

Show number

Ongoing studies

A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

Recruiting

2 1
Investigated drugs:
- XMAB942
+5
Orforglipron for stress urinary incontinence in women with obesity or overweight

Recruiting

3 1
Investigated diseases:
- Stress
- Urinary incontinence
Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

Recruiting

3 1 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Recruiting

3 1 1
Investigated diseases:
- Chronic kidney disease
- Hypertension
Investigated drugs:
- Baxdrostat
- Dapagliflozin
+9
Study of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer

Recruiting

3 1 1
Investigated diseases:
- Bladder transitional cell carcinoma
Investigated drugs:
- NADOFARAGENE FIRADENOVEC
Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

Recruiting

2 1
Investigated drugs:
- Humanised Igg4 Kappa Monoclonal Antibody Against Cxcl1, Cxcl2, Cxcl3, Cxcl5, Cxcl6, Cxcl7 And Cxcl8
- Mirikizumab
+8
A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Not yet recruiting

3 1 1
Investigated diseases:
- Bladder cancer
- Bladder transitional cell carcinoma
Investigated drugs:
- (S)-4-(4-(3-CHLORO-4-(1-(5-FLUOROPYRIDIN-2-YL)-2-HYDROXYETHOXY)PYRAZOLO[1,5-A]PYRIDIN-6-YL)-5-METHYL-1H-1,2,3-TRIAZOL-1-YL)PIPERIDINE-1-CARBONITRILE
+3
Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

Not yet recruiting

3 1 1
Investigated drugs:
+6
A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

Not recruiting

3 1
Investigated diseases:
Investigated drugs:
- Cagrilintide
- Semaglutide
Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

Not recruiting

3 1
Investigated drugs:
- Fezolinetant
+3

#1 Clinical Trials Search in Europe

Medical Concierge Centrum Medyczne Ul. Polnej Rozy 6/u2, Warsaw, 02-798, Poland

About Specializations

Medical Center localisation

Ongoing studies

A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis

Orforglipron for stress urinary incontinence in women with obesity or overweight

Study of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Study of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer

Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

A study of loxo-435, enfortumab vedotin, and pembrolizumab in adults with advanced or metastatic bladder cancer

Study on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients

A Study of Cagrilintide and Semaglutide for Weight Loss in People with Type 2 Diabetes and Overweight or Obesity

Study of Fezolinetant for Hot Flashes in Women with Hormone Receptor-Positive Breast Cancer Receiving Hormone Therapy

Medical Concierge Centrum Medyczne Ul. Polnej Rozy 6/u2, Warsaw, 02-798, Poland

About Specializations

Medical Center localisation

Ongoing studies

We use cookies